Trial of Curcumin in Advanced Pancreatic Cancer - Related Studies

Trial of Curcumin in Advanced Pancreatic Cancer

This study has been completed.

Study NCT00094445. Last updated on March 19, 2007. Information provided by M.D. Anderson Cancer Center

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pancreatic Neoplasms
		Adenocarcinoma

2	Additional conditions recognized in this trial
		Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Digestive System Diseases
		Digestive System Neoplasms
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Pancreatic Diseases

4	Interventions listed in this trial
		Curcumin (diferuloyl methane)

5	Additional drug interventions recognized in this trial
		Curcumin

6	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antineoplastic Agents
		Antirheumatic Agents
		Central Nervous System Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		M.D. Anderson Cancer Center